InvestorsHub Logo
icon url

donkey40

06/07/21 5:56 PM

#3145 RE: apdp #3144

Yes, that is a really great idea. If all VT shareholders supported Dan then he would have a few quid to be able to settle his many debts. Maybe that would restore his faith in humankind.

Does Zhittya have any patents, assets or revenue streams?? Does anyone know - if you do, please share with us all. And if Zhittya does, then fabulous news because they can use the registered patents or assets to raise funds to endeavour to progress their science. And that would be a really good thing for humankind as well.

I am sure there are noticeable and distinct differences in the Zhittya patents and science v the CVBT patents and science. That is good, because we really would not want further litigation on the merits or otherwise of copycat science. All shareholders in CVBT and Zhittya have surely had enough of that by now. I know I have.

It is good that Zhittta has been progressing its science in Mexico since that is a different market, different type of patient and different health regulator as compared to what CVBT is looking to do in the US. Yes, very good that Dan had the common sense to pursue his science (even though it is remarkably similar to CVBT science) in a different country. Let us keep potential litigation to an absolute minimum I say !!

I must admit, I have never felt more confident that Dan’s science in Mexico and Calvin’s science in USA is getting on track. Finally both will be able to do good things for mankind. And in these latter stages Covid pandemic, I will happily take all good news possible.

So thank you both. I hope you have a fair wind and you make great progress and headway. And also that the biotech regulators support both scientific endeavours fully. God speed !!
icon url

BinkyRise

06/09/21 2:32 PM

#3181 RE: apdp #3144

It is actually $1.7m that Montano owes VT.


The arbitration awarded Montano $800,000 but the there was $2.5m outstanding that Montano owed VT so it nets out at $1.7m.
VT are going after him now for the $1.7m